Results 81 to 90 of about 18,018 (235)
Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review
Addiction, EarlyView.Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper +7 more
wiley +1 more source
Behavioral and Brain Functions, 2010 Background Numerous reports indicate that MDMA users consume other psychoactive drugs, among which cannabis is one of the most common. The aim of the present study was to evaluate, using the conditioned place preference, the effect of the cannabinoid ...
Miñarro José +5 more
doaj +1 more source
Addiction, EarlyView.Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens +7 more
wiley +1 more source
Motives for MDMA Use: A Comparative Study with Alcohol and Cannabis
European PsychiatryIntroduction While research on drug use motives has primarily focused on widely used substances like alcohol, tobacco, and cannabis, understanding the motivations behind MDMA use is crucial for developing targeted therapeutic, preventive, and harm ...
D. Zullino +6 more
doaj +1 more source
The ameliorating effects of Vitamin E on hepatotoxicity of ecstasy
Journal of Research in Medical Sciences, 2020 Background: The production of stress oxidative condition in body which is caused by consumption of ecstasy (3,4-methylenedioxymethamphetamine [MDMA]) leads to a liver damage.
Masoumeh Zirak Javanmard +3 more
doaj +1 more source
Has Australia lost control of its tobacco and nicotine markets?
Addiction, EarlyView.Abstract Background Australia has adopted two policies that the World Health Organization (WHO) recommends as best practice for tobacco control: it has steeply increased tobacco taxes since 2010 and only allowed access to nicotine vapes for medical use.
Ron Borland +4 more
wiley +1 more source
A survey of novel MDA and MDMA precursors by isotope ratio mass spectrometry
, 2021 Presented is a survey of the hydrogen, carbon and oxygen isotope profiles of traditional and novel precursors and pre-precursors used for the synthesis of 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethylamphetamine (MDMA).
Matheson, C +9 more
core +1 more source
Lifetime MDMA use and associations with meaning in life in the context of childhood trauma
Scientific ReportsRecent research has highlighted the potential of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for the treatment of post-traumatic stress disorder and other trauma-related psychiatric conditions. However, less is known about the effects
Michelle Olofsson +7 more
doaj +1 more source
Addiction, EarlyView.Abstract Aims To determine: (1) Population rates of fatal methylenedioxymethamphetamine (MDMA)‐related poisoning over the period 2016–2023, years with high closure rates in the National Coronial Information System (NDIS); (2) the case characteristics of known cases of fatal MDMA‐related poisoning, 2016–2025; and (3) whether there have been changes in ...
Shane Darke +5 more
wiley +1 more source
Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling [PDF]
, 2015 Novel psychoactive substances are newly used designer drugs ("internet drugs", "research chemicals", "legal highs") potentially posing similar health risks to classic illicit substances. Chemically, many novel psychoactive substances can be classified as
Liechti, Matthias E. +2 more
core +1 more source